Page last updated: 2024-09-05

erlotinib hydrochloride and Memory Disorders

erlotinib hydrochloride has been researched along with Memory Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiang, HC; Du, S; Liang, B; Ma, W; Wang, L; Wu, W; Xie, Z; Yao, X; Zhong, Y	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Memory Disorders

Article	Year
Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss. Proceedings of the National Academy of Sciences of the United States of America, 2012, Oct-09, Volume: 109, Issue:41 Topics: Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Blotting, Western; Chlorocebus aethiops; COS Cells; Drosophila; Drosophila Proteins; Drug Evaluation, Preclinical; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Maze Learning; Memantine; Memory; Memory Disorders; Mice; Mice, Transgenic; Molecular Structure; Peptide Fragments; Protein Kinase Inhibitors; Quinazolines	2012

Article

Year

Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss.

Proceedings of the National Academy of Sciences of the United States of America, 2012, Oct-09, Volume: 109, Issue:41

Topics: Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Blotting, Western; Chlorocebus aethiops; COS Cells; Drosophila; Drosophila Proteins; Drug Evaluation, Preclinical; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Maze Learning; Memantine; Memory; Memory Disorders; Mice; Mice, Transgenic; Molecular Structure; Peptide Fragments; Protein Kinase Inhibitors; Quinazolines

2012